Tempus has launched an upgraded version of its Lens platform, enhancing its agentic AI capabilities for oncology drug development. This new iteration aims to accelerate the discovery and application of new treatments by leveraging advanced AI tools. The expansion focuses on improving how AI agents interact with complex biological data to identify promising drug candidates and personalize cancer therapies. AI
IMPACT Enhances AI's role in accelerating oncology research and drug discovery.
RANK_REASON Product update for an existing AI platform.
Read on Mastodon — sigmoid.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
